Search Results - "ZARZOSO, JENNIFER"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    PHARMACOKINECTS STUDY TO EVALUATE DRUG-DRUG INTERACTIONS (DDI) BETWEEN HZN-825 AND PIRFENIDONE/NINTEDANIB

    PHARMACOKINECTS STUDY TO EVALUATE DRUG-DRUG INTERACTIONS (DDI) BETWEEN HZN-825 AND PIRFENIDONE/NINTEDANIB by SONG, YANG, HUDSON, KRISCHAN, YE, ZHAN, CHEN, WEI, HAWLEY, LISA, ZARZOSO, JENNIFER, ROGOWSKI, JOHN, SIEBERS, NICHOLAS, VOSKUHL, GENE, SUN, YAJING, XIN, YAN

    Published in Chest (01-10-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Pharmacokinetics of Fipaxalparant, a Small‐Molecule Selective Negative Allosteric Modulator of Lysophosphatidic Acid Receptor 1, and the Effect of Food in Healthy Volunteers

    Pharmacokinetics of Fipaxalparant, a Small‐Molecule Selective Negative Allosteric Modulator of Lysophosphatidic Acid Receptor 1, and the Effect of Food in Healthy Volunteers by Song, Yang, Ali, Farah N., Ye, Zhan, Zarzoso, Jennifer, Rogowski, John, Sun, Yajing, Xin, Yan

    Published in Clinical pharmacology in drug development (01-07-2024)
    “…Dysregulated lysophosphatidic acid receptor 1 (LPAR1) signaling is implicated in fibrotic diseases, including systemic sclerosis (SSc) and idiopathic pulmonary…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: